Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abivax, Aldeyra, Alterity, Amgen, Ascentage, Aurobindo, Beigene, Bharat, Biontech, Cocrystal, Cullinan Oncology, Halberd, Hyundai, IMV, Merck, Ocugen, Open Orphan, Pfizer, Prep Biopharm, Recce, Resverlogix, Soligenix, Tonix, United Biomedical, Unity, Zai Lab.
Biopharmas in Asia-Pacific raising money in public or private financings, including: Arch Biopartners, Epsilon Molecular Engineering, Foresee, Gracell, Transcenta.
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: U.S. FDA provides updates on power morcellation; FDA seeks nominations for advisory committee; CDSCO suspends import notification requirements.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Distalmotion, Inex Innovate, Quanterix.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Collagen Matrix, Degradable Solutions, Dilon Technologies, Digirad, Dw Healthcare Partners, Eyenovia, Orthopediatrics, Smart Breast, Star Equity Holdings, Teleflex, Z-Medica.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alkermes, Ampio, Arcturus, Capricor, Celltrion, Clovis, Chi-Med, Moleculin, Novo Nordisk, Pfizer.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcturus, Biontech, Brand Institute, Cognition, Innovare, Junshi, Karolinska, Olatec, Pfizer, Pluristem, Umecrine.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Arcturus, Intra-Cellular, Nanology, VBL.